STRATA Skin Sciences Announces The Placement Of Six XTRAC Devices With Dermatology Clinics In Q1 Of 2024 That Are Considered "Comebacks"
Portfolio Pulse from Benzinga Newsdesk
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) announced the placement of six XTRAC devices with dermatology clinics in Q1 of 2024, marking significant 'comebacks' from clinics that had previously left but have now rejoined STRATA's partner program. These include notable clinics like Henry Ford Health System, Integrated Dermatology Group, and Schweiger Dermatology Group. This move is seen as a validation of STRATA's partner program and is part of a broader strategy to increase device utilization and average revenue per device through direct-to-consumer marketing and efforts to regain lapsed customers.
April 30, 2024 | 12:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
STRATA Skin Sciences announces the successful placement of six XTRAC devices in Q1 2024 with returning dermatology clinics, highlighting the strength and appeal of its partner program.
The announcement of the placement of six XTRAC devices with returning dermatology clinics, including high-profile names like Henry Ford Health System and Integrated Dermatology Group, serves as a strong endorsement of STRATA's partner program. This move not only validates the program's value proposition but also signals potential revenue growth from increased device utilization and direct-to-consumer marketing efforts. The positive reception from previously lapsed clinics suggests a robust demand for STRATA's offerings, likely leading to a positive short-term impact on SSKN's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100